W8 Severe Asthma (MOC)

You can earn up to 2.0 AMA PRA Category 1 Credit(s)™. This activity has also been designated by the ABAI for 2.0 MOC Part II Self-Assessment credits. Cost: $40 $20 for College Members, $60 $30 for non-members.

This workshop will discuss the evaluation process and approach to management of difficult to control asthma in children.


Release Date: 12/15/2015
Expiration Date: 12/14/2018


The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

• Describe how severe asthmatics are uniquely different and review the evaluation/assessment of these patients, comparing pediatric and adult and develop a treatment plan for patients with severe asthma

Additional information

Leonard B. Bacharier, MD, FACAAI -- Consultant/Advisor: Boehringer Ingelheim, DBV Technologies, GlaxoSmithKline, Meda,Teva; Speaker: AstraZeneca, Novartis 

Reynold A. Panettieri, Jr., MD -- Consultant/Advisor: AstraZeneca, Johnson & Johnson; Supported/Contracted Research: Gilead, Johnson & Johnson, Merck, Roche, Sanofi

Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Attendance
  • 2.00 MOC
Course opens: 
Course expires: 

Leonard B. Bacharier, MD, FACAAI 

Reynold A. Panettieri, MD

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Attendance
  • 2.00 MOC


Please login or create an account to take this course.